Reference,Reference: DOI,Assay,Section,Infection (CP),Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1B,Wild Type,1m,Human,Wild Type (B.1),=,1391.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,720.0,1.0,=,1.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1B,Wild Type,1m,Human,Wild Type (B.1),=,272.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,64.0,1.0,=,4.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1B,Wild Type,1m,Human,Wild Type (B.1),=,282.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,131.0,1.0,=,2.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1B,Wild Type,1m,Human,Wild Type (B.1),=,315.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,240.0,1.0,=,1.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1B,Wild Type,1m,Human,Wild Type (B.1),=,865.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,350.0,1.0,=,2.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1B,Wild Type,1m,Human,Wild Type (B.1),=,818.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,207.0,1.0,=,4.0